The target audience for these events is medical trainees of all grades including medical students, junior consultants and allied health professionals. It will be available as a benefit of BTOG membership and therefore participants must be a BTOG member to participate. If you forward this information to trainees not yet BTOG members, they can easily join BTOG here.
BTOG is proud to bring you a regular virtual journal club on the latest trials in thoracic oncology facilitated by experts and discussing all things from trial design to results interpretation and their implications for clinical practice. This is a fantastic opportunity to discuss landmark trials with experts and peers and definitely not one to be missed!
Our April BTOG Journal Club is on Wednesday 27th April 2022
Expert: Dr Tom Newsom-Davis
Paper to be discussed: Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN. Paz-Ares et al. ESMO open.
In order to be fully interactive and maximise the educational value there will be limited spaces. You can register on Eventbrite.
Participants are expected to:
- Sign in on time (giving adequate notice if unable to attend)
- Read the journal article prior to the Journal Club
- Consider the pre-session questions in preparation
- Contribute to the discussion
- Give constructive feedback on the Journal Club
We will send out further information including a PDF of the article, pre-session questions and how to join the Zoom meeting before the event to successful participants.
Any questions please contact the BTOG Team – email@example.com